By Emeritus Professor John Murray

Journal articles

Shaddock EJ; Richards GA; Murray J, 2012, 'Lung fibrosis in deceased HIV-infected patients with Pneumocystis pneumonia', Southern African Journal of HIV Medicine, 13, pp. 64 - 67, http://dx.doi.org/10.4102/sajhivmed.v13i2.140

Mota T; Murray JM; Center R; Purcell D; McCaw J, 2012, 'Application of a case-control study design to investigate genotypic signatures of HIV-1 transmission', Retrovirology, 9, pp. 54, http://dx.doi.org/10.1186/1742-4690-9-54

Murray JM; McBride K; Boesecke C; Bailey MR; Amin J; Suzuki K; Baker D; Zaunders JJ; Emery S; Cooper DA; Koelsch KK; Kelleher AD, 2012, 'Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards', AIDS, 26, pp. 543 - 550, http://dx.doi.org/10.1097/QAD.0b013e328350fb3c

Chakrabarty SP; Murray JM, 2012, 'Modelling hepatitis C virus infection and the development of hepatocellular carcinoma', Journal of Theoretical Biology, 305, pp. 24 - 29, http://dx.doi.org/10.1016/j.jtbi.2012.03.030

Savkovic B; Symonds G; Murray JM, 2012, 'Stochastic model of in-vivo X4 emergence during HIV infection: implications for the CCR5 inhibitor maraviroc', PLoS ONE, 7, pp. 1 - 14, http://dx.doi.org/10.1371/journal.pone.0038755

Savkovic B; Macpherson JL; Zaunders J; Kelleher A; Knop A; Pond S; Evans L; Symonds G; Murray JM, 2012, 'T-lymphocyte perturbation following large-scale apheresis and hematopoietic stem cell transplantation in HIV-infected individuals', Clinical Immunology, 144, pp. 159 - 171, http://dx.doi.org/10.1016/j.clim.2012.06.004

Vallely A; MacLaren DJ; Kaleva W; Millan J; Tommbe R; Marape W; Manineng C; Buchanan H; Amos A; Frank R; Kelly A; Kupul M; Aeno H; Trowalle E; John LN; Redman-Maclaren ML; Ryan C; Browne K; Tynan A; Hill PS; Gray RT; Murray J; Wilson DP; Law G; Siba P; McBride WJ; Farley T; Kaldor JM; National Policy Forum, Papua New Guinea , 2011, 'Male circumcision for HIV prevention in Papua New Guinea: a summary of research evidence and recommendations for public health following a national policy forum.', Papua and New Guinea medical journal, 54, pp. 91 - 108

Fernandez S; Tanaskovic S; Helbig K; Rajasuriar R; Kramski M; Murray JM; Beard M; Purcell DJ; Lewin S; Price P; French MA, 2011, 'CD4+ T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4+ T cells', Journal of Infectious Diseases, 204, pp. 1925 - 1927, http://dx.doi.org/10.1093/infidis/jir659

Murray JM; Ritter A, 2011, 'Findings regarding reduced prevalence with hepatitis C treatment are still valid: a reply to Vickerman et al', Drug and Alcohol Dependence, 113, pp. 86 - 87, http://www.sciencedirect.com/science/article/B6T63-5119FTB-4/2/1da704a3e06e8182fdff46a2d32dd183

Koelsch KK; Boesecke C; Mcbride K; Gelgor L; Fahey P; Natarajan V; Baker D; Bloch M; Murray JM; Zaunders J; Emery S; Cooper DA; Kelleher AD, 2011, 'Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir', AIDS, 25, pp. 2069 - 2078, http://dx.doi.org/10.1097/QAD.0b013e32834b9658

Murray JM; Prestage G; Grierson J; Middleton MG; Mcdonald A, 2011, 'Increasing HIV diagnoses in Australia among men who have sex with men correlated with the growing number not taking antiretroviral therapy', Sexual Health, 8, pp. 304 - 310, http://www.publish.csiro.au/paper/SH10114

Cysique LA; Bain MP; Brew BJ; Murray JM, 2011, 'The burden of HIV-associated neurocognitive impairment in Australia and its estimates for the future', Sexual Health, 8, pp. 541 - 550, http://search.informit.com.au/documentSummary;dn=535898181780976;res=IELHEA

Murray JM; Kelleher ; Cooper DA, 2011, 'Timing of the components of the HIV life cycle in productively infected CD4+ T cells in a population of HIV-infected individuals', Journal of Virology, 85, pp. 10798 - 10805, http://dx.doi.org/10.1128/JVI.05095-11

Pett SL; Zaunders J; Bailey M; Murray JM; Macrae K; Emery S; Cooper DA; Kelleher AD, 2010, 'A novel Chemokine-Receptor-5 (CCR5) blocker, SCH532706, has differential effects on CCR5+CD4+ and CCR5+CD8+ T cell numbers in chronic HIV infection', AIDS Research and Human Retroviruses, 26, pp. 653 - 661, http://dx.doi.org/10.1089/aid.2009.0278

Cysique LA; Murray JM; Dunbar M; Jeyakumar V; Brew BJ, 2010, 'A screening algorithm for HIV associated neurocognitive disorders', HIV Medicine, 11, pp. 642 - 649, http://dx.doi.org/10.1111/j.1468-1293.2010.00834.x

Applegate TL; Birkett DJ; Mcintyre GJ; Jaramillo AB; Symonds G; Murray JM, 2010, 'In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy', Retrovirology, 7:83, pp. 1 - 14, http://www.retrovirology.com/content/7/1/83

Lutgehetmann M; Volz T; Kopke A; Broja T; Tigges E; Lohse AW; Fuchs E; Murray JM; Petersen J; Dandri M, 2010, 'In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice', Hepatology, 52, pp. 16 - 24, http://dx.doi.org/10.1002/hep.23611

Londish GJ; Templeton DJ; Regan DG; Kaldor JM; Murray JM, 2010, 'Minimal impact of circumcision on HIV acquisition in men who have sex with men', Sexual Health, 7, pp. 463 - 470, http://dx.doi.org/10.1071/SH09080

Koelsch KK; Xu Y; Bailey M; McBride K; Seddiki N; Suzuki K; Murray J; Cooper DA; Kelleher AD; Zaunders J, 2010, 'Most HIV DNA in PBMC is present in non‐gut homing, resting memory CD4+ T cells with a ß7‐CD38‐CD127 high phenotype', Journal of the International AIDS Society, 13, http://dx.doi.org/10.1186/1758-2652-13-s3-o2

Zeiler I; Langlands TA; Murray JM; Ritter A, 2010, 'Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs', Drug and Alcohol Dependence, 110, pp. 228 - 233, http://www.sciencedirect.com/science/article/B6T63-4YYGPNG-1/2/fdcaccba640e0cc879679e1def9e1354

Dunbar M; Murray JM; Cysique LA; Brew BJ; Jeyakumar V, 2010, 'Simultaneous classification and feature selection via convex quadratic programming with application to HIV-associated neurocognitive disorder assessment', European Journal of Operational Research, 206, pp. 470 - 478, http://www.sciencedirect.com/science/article/B6VCT-4YM7FH3-4/2/a3b9972e52fd64b1f7b5439ecdb15184

Vallely A; Page A; Dias S; Lupiwa T; Law G; Millan J; Wilson DP; Murray JM; Toole M; Kaldor JM, 2010, 'The Prevalence of Sexually Transmitted Infections in Papua New Guinea: A Systematic Review and Meta- Analysis', PLoS One, 5, pp. 1 - 10, http://dx.doi.org/10.1371/journal.pone.0015586

Murray JM; Vallely A; Page A, 2010, 'When the presumption of innocence is not beneficial: periodic presumptive treatment for STIs and HIV in female sex workers', Sexually Transmitted Infections, 86, pp. 161 - 162, http://sti.bmj.com/content/86/3/161.short

Mcintyre GJ; Yu Y; Tran A; Jaramillo AB; Arndt AJ; Millington ML; Boyd MP; Elliott FA; Shen SW; Murray JM; Applegate TL, 2009, 'Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success', Virology Journal, 6, pp. 184, http://www.virologyj.com/content/6/1/184

Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA, 2009, 'Evolution of CD4+T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression', AIDS Research and Human Retroviruses, 25, pp. 569 - 576

Murray JM; Fanning GC; Macpherson JL; Evans LA; Pond SM; Symonds GP, 2009, 'Mathematical modelling of the impact of haematopoietic stem cell-delivered gene theraphy for HIV', Journal of Gene Medicine, 11, pp. 1077 - 1086, http://dx.doi.org/10.1002/jgm.1401

Mitsuyasu RT; Merigan T; Carr AD; Zack J; Winters M; Workman C; Bloch MT; Lalezari J; Becker S; Thornton L; Akil B; Khanlou H; Finlayson R; Mcfarlane R; Smith DE; Garsia R; Ma DD; Law MG; Murray JM; Von Kalle C; Ely JA; Patino S; Knop A; Wong P; Todd A; Haughton M; Fuery C; Marcpherson J; Symonds G; Evans L; Pond SM; Cooper DA; Cooper D; Han A, 2009, 'Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells', Nature Medicine, 15, pp. 285 - 292, http://dx.doi.org/10.1038/nm.1932

Murray JM; McDonald AM; Law MG, 2009, 'Rapidly ageing HIV epidemic among men who have sex with men in Australia', Sexual Health, 6, pp. 83 - 86, http://www.publish.csiro.au/paper/SH08063

Dandri M; Petersen J; Murray JM, 2009, 'Reply: Hepatitis B virus clearance rate estimates', Hepatology, 49, pp. 1780 - 1781, http://dx.doi.org/10.1002/hep.22918

Byakwaga H; Murray JM; Petoumenos K; Boyd MA; Emery S; Mallon PW; Cooper DA, 2008, 'Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression', Journal of the International AIDS Society, 11, http://dx.doi.org/10.1186/1758-2652-11-s1-p70

Srinivasan S; Holmyard D, 2008, 'Corneal stromal bed quality obtained with mechanical microkeratome and femtosecond laser.', Cornea, 27, pp. 746, http://dx.doi.org/10.1097/QAI.0b013e31815dbf7f

Murray JM, 2008, 'HIV dynamics and integrase inhibitors', Antiviral Chemistry and Chemotherapy, 19, pp. 157 - 164

Londish GJ; Murray JM, 2008, 'Significant reduction in HIV prevalence according to male circumcision intervention in sub-saharan Africa', International Journal of Epidemiology

Dandri M; Murray JM; Lutgehetmann M; Volz T; Lohse A; Petersen J, 2008, 'Virion half-life in chronic hepatitis B infection is strongly correlated with levels of viremia', Hepatology, 48, pp. 1079 - 1086

Lewin S; Murray JM; Solomon A; Wightman F; Cameron P; Purcell DJ; Zaunders J; Grey PA; Bloch M; Smith DE; Cooper DA; Kelleher AD, 2008, 'Virologic determinants of success after structured treatment interruptions in antiretrovirals in acute HIV-1 infection', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 47, pp. 140 - 147

Murray JM; Emery S; Kelleher AD; Law MG; Chen J; Hazuda DJ; Nguyen BT; Teppler H; Cooper DA, 2007, 'Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase', AIDS, 21, pp. 2315 - 2321

Volz T; Lutgehetmann M; Wachtler P; Jacob A; Quaas A; Murray JM; Dandri M; Petersen J, 2007, 'Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients', Gastroenterology, 133, pp. 843 - 852

Murray JM; Purcell RH; Wieland SF, 2006, 'The half-life of Hepatitis B virions', Hepatology, 44, pp. 1117 - 1121

Murray JM; Wieland SF; Purcell RH; Chisari FV, 2005, 'Dynamics of hepatitis B virus clearance in chimpanzees', Proceedings of the National Academy of Sciences of the United States of America, 102, pp. 17780 - 17785

Murray JM; Perelson AS, 2005, 'Human immunodeficiency virus: Quasi-species and drug resistance', Multiscale Modeling and Simulation, 3, pp. 300 - 311

Macpherson JL; Boyd MP; Arndt AJ; Todd AV; Ganning GC; Ely JA; Elliott F; Knop A; Raponi M; Murray JM; Gerlach W; Sun L; Penny R; Symonds GP; Carr AD; Cooper DA, 2005, 'Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients', Journal of Gene Medicine, 7, pp. 552 - 564

Murray JM; Leigh Brown AJ; Frost SDW; Mathews WC; Dawson K; Hellmann NS; Daar ES; Richman DD; Little SJ, 2003, 'Changing Transmission Fitness of Drug-Resistant Human Immunodeficiency Virus against a Background of Evolving Antiretroviral Therapy [1] (multiple letters)', Journal of Infectious Diseases, 188, pp. 1258 - 1259, http://dx.doi.org/10.1086/378679

Murray JM; Kaufmann GR; Hodgkin PD; Lewin SR; Kelleher AD; Davenport MP; Zaunders JJ, 2003, 'Naive T cells maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty', Immunology and Cell Biology, 81, pp. 487 - 495

Murray JM; Coldman AJ, 2003, 'The effect of heterogeneity on optimal regimens in cancer chemotherapy', Mathematical Biosciences, 185, pp. 73 - 87

Murray JM; Law MG; Gao Z; Kaldor JM, 2003, 'The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users', International Journal of Epidemiology, 32, pp. 708 - 714, http://ije.oxfordjournals.org/content/32/5/708.abstract

Markowitz M; Jin XC; Hurley A; Simon V; Ramratnam B; Louie M; Deschenes GR; Ramanathan JM; Barsoum S; Vanderhoeven J; He T; Chung C; Murray JM; Perelson AS; Zhang L; Ho D, 2002, 'Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination', Journal of Infectious Diseases, 186, pp. 634 - 643

Whalley SA; Murray JM; Brown D; Webster GJ; Emery VC; Dusheiko G; Perelson AS, 2001, 'Kinetics of acute hepatitis B virus infection in humans', Journal of Experimental Medicine, 193, pp. 847 - 853

Kaufmann GR; Zaunders J; Murray JM; Kelleher AD; Lewin S; Solomon A; Smith DE; Cooper DA, 2001, 'Relative significance of different pathways of immune reconstitution in HIV type 1 infection as estimated by mathematical modelling.', AIDS Research and Human Retroviruses, 17, pp. 147 - 159

Whalley SA; Murray JM; Brown D; Webster GJM; Emery VC; Dusheiko GH; Perelson AS, 2000, 'The kinetics of acute hepatitis B virus infection in humans.', HEPATOLOGY, 32, pp. 446A - 446A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000089622401131&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Coldman AJ; Murray JM, 2000, 'Optimal control for a stochastic model of cancer chemotherapy', Mathematical Biosciences, 168, pp. 187 - 200

Back to profile page